Skip to main content
logo
Recce Pharmaceuticals Ltd (ASX:RCE)
Australia flag Australia · Delayed Price · Currency is AUD
0.3550
-0.0050 (-1.39%)
Sep 2, 2026, 1:32 PM AEST

Recce Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-14.96-21.43-17.66-13.08-10.99
Depreciation & Amortization
0.070.360.370.220.19
Loss (Gain) From Sale of Investments
0.53----
Stock-Based Compensation
1.071.340.020.330.26
Other Operating Activities
0.29----
Change in Accounts Receivable
-3.440.280.060.090.06
Change in Accounts Payable
5.74-0.533.810.770.11
Change in Other Net Operating Assets
0.82-0.460.39-1.011.36
Operating Cash Flow
-9.89-20.44-13.01-12.69-9.01
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0.06-0.03-0.14-0.04-0.04
Investment in Securities
-0-0.24---
Other Investing Activities
0.19-0.18-0.16--
Investing Cash Flow
0.12-0.44-0.3-0.04-0.04

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
---2.88-
Long-Term Debt Issued
0.0612.2210.09--
Total Debt Issued
0.0612.2210.092.88-
Long-Term Debt Repaid
-1.71-11.92-4.51-0.17-0.14
Total Debt Repaid
-1.71-11.92-4.51-0.17-0.14
Net Debt Issued (Repaid)
-1.660.315.582.71-0.14
Issuance of Common Stock
3.9428.3511.150.10.29
Other Financing Activities
-0.27-1.74-0.56-0.1-0.39
Financing Cash Flow
2.0126.9216.172.71-0.24

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Miscellaneous Cash Flow Adjustments
0---0
Net Cash Flow
-7.756.032.85-10.02-9.29

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-9.95-20.47-13.15-12.73-9.05
Free Cash Flow Growth
-----
Free Cash Flow Margin
-100.15%-272.59%-261.53%-291.53%-293.38%
Free Cash Flow Per Share
-0.03-0.09-0.07-0.07-0.05
Levered Free Cash Flow
-0.29-12.6-7.73-8.16-4.52
Unlevered Free Cash Flow
0.75-11.84-7.21-8.05-4.51

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
--6.74-4.91-4.31-3.08
Change in Working Capital
3.12-0.714.27-0.151.53